Allianz Asset Management Gmb H Pacific Biosciences Of California, Inc. Transaction History

Allianz Asset Management Gmb H

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$19.26 - $30.08 $151,788 - $237,060	-7,881 Reduced 13.59%	50,096 $1.03 Million
Q3 2021 Nov 10, 2021	BUY	$24.86 - $35.02 $1.03 Million - $1.45 Million	41,450 Added 250.8%	57,977 $1.48 Million
Q2 2021 Aug 16, 2021	SELL	$22.3 - $36.02 $1.01 Million - $1.63 Million	-45,191 Reduced 73.22%	16,527 $578,000
Q1 2021 May 13, 2021	SELL	$26.38 - $51.15 $566,167 - $1.1 Million	-21,462 Reduced 25.8%	61,718 $2.06 Million
Q4 2020 Feb 16, 2021	SELL	$10.5 - $28.5 $887,250 - $2.41 Million	-84,500 Reduced 50.39%	83,180 $2.16 Million
Q3 2020 Nov 13, 2020	BUY	$3.61 - $9.87 $605,324 - $1.66 Million	167,680 New	167,680 $1.66 Million
Q1 2019 May 13, 2019	SELL	$6.8 - $7.4 $3.14 Million - $3.41 Million	-461,225 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$3.99 - $7.82 $1.84 Million - $3.61 Million	461,225 New	461,225 $3.41 Million
Q2 2017 Aug 14, 2017	SELL	N/A	-396,075 Closed	0 $0
Q1 2017 Apr 17, 2019	SELL	N/A	-22,000 Reduced 5.26%	396,075 $2.05 Million
Q4 2016 Apr 17, 2019	SELL	N/A	-175,031 Reduced 29.51%	418,075 $1.59 Million
Q3 2016 Apr 17, 2019	BUY	N/A	593,106	593,106 $5.31 Million

254

228M

745K

1.23M

Ticker PACB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 224,840,992
Market Cap $438M
Description
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...

Get notified when there are updates to the investment portfolio of Allianz Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Allianz Asset Management Gmb H with notifications on news.